Auris Health, Inc. Stock
Robotic endoscopy medical device company
Sign up today and learn more about Auris Health, Inc. Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Auris Health, Inc. Stock
Auris Health develops robotics technology for endoscopy - a nonsurgical medical procedure used to examine a person's digestive tract. The Company currently has one offering: Monarch Platform. The Monarch Platform and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures. According to the company, its Monarch Platform improves upon existing minimally invasive techniques by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform to enable new categories of care. The Company states that lung cancer is the first disease it is targeting.
Auris had been in "stealth" for nearly a decade, but in March 2018, it attained FDA approval for its Monarch Platform to be used for "bronchoscopic procedures," such as diagnosing lung cancer.
The Company was incorporated in 2007 and is based in the San Francisco Bay area.
Bronchoscopy Overview:
Source: Crunchbase; Auris
Investors
Highland Capital Partners
Scopely, Auris Health, Inc., Welltok, Rent the Runway, Enjoy, Qumulo, EverlyWell, Carbon Black, Turbonomic, Tomorrow.io
Lux Capital
Anduril Industries, Relativity Space, Auris Health, Inc., Carbon Health, Anchorage Digital, Flutterwave, Hugging Face, Astranis, Desktop Metal, Benchling
Mithril Capital Management
Palantir Technologies, Auris Health, Inc., C2FO, AppDirect, Lookout, Figure, Spaceflight Industries, GreyOrange, Stem, DoubleDutch
NaviMed Capital
Funding History
| May 2009 | $1.6M |
|---|---|
| June 2011 | $9.7M |
| August 2012 | $1.4M |
| March 2014 | $33.0M |
| September 2015 | $208M |
| June 2017 | $280M |
| November 2018 | $220M |
Management
Co-Founder & CEO
Fred Moll
Chief Strategy Officer
Josh DeFonzo
CFO
David Styka
VP of Operations
Dan Bradford
VP of Sales
Eric Davidson
VP of Engineering
Richard Leparmentier
VP of R&D
David Mintz
VP of Business Development
David Schummers
Press
Xconomy - Nov, 28 2018
Auris Health Lands $220M to Expand Sales of Lung Testing Medical RobotThe FentonPost - Sep, 15 2018
Medical Robotics and Computer-Assisted Surgery Market to 2025 Analysis and In-depth Research on Market Size ...Newszak (blog) - Sep, 8 2018
Computer Assisted Surgical Systems Market to Perceive Substantial Growth During 2018–2026 : Intuitive surgical, Inc ...The City Chronicle - Aug, 28 2018
Medical Robots Market Global Share 2018 with Growing CAGR of 21.30% by 2023theperfectinvestor.com - Jun, 19 2018
Medical Robot Market to witness Impressive Global Growth in Production-Consumption Ratio through 2025Mass Device - May, 22 2018
Auris Health named to CNBC Disruptor 50 listMass Device - May, 16 2018
Auris Health, Ethicon's NeuWave ink robot-assisted bronchoscope ablation dev dealTechCrunch - Mar, 24 2018
Monarch is a new platform from surgical robot pioneer Frederic MollFierceBiotech - Mar, 23 2018
After raising $500M, Fred Moll's Auris gets FDA nod for lung cancer robotic platformBusinessWire - Mar, 23 2018
Auris Health Unveils the FDA-Cleared Monarch Platform, Ushering in a New Era of Medical InterventionTechCrunch - Aug, 4 2017
Auris Surgical Robotics, founded by superstar Fred Moll, has quietly closed on a ton of moneyMilTech - May, 3 2017
Robotic Surgery Market 2017: Overview, Top Manufactures, Market Demands, Opportunities, In-Depth Analysis and ...Med Device Online (press release) - Dec, 15 2016
Surgical Robotics: A Snapshot Of The Current Global MarketMass Device - Jul, 28 2016
Auris Surgical Robotics closes $80m Hansen Medical buyMed Device Online (press release) - Jun, 10 2016
Auris Enters Robotic Surgery Market With FDA Nod For Bronchoscopemassdevice - Jan, 22 2016
Intuitive Surgical CEO Guthart unfazed by upcoming competitionEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
